Nan Fung Life Sciences

Nan Fung Life Sciences

Nan Fung Life Sciences

Pulse 2.0

Eargo Stock (EAR): Why The Price Surged Today

The Verge

Eargo’s new hearing aids can automatically adjust to your environment

Pulse 2.0

Aptinyx Stock (APTX): Why The Price Increased Today


Oculis raises $57m Series C led by BVCF Management and Hyfinity Investments

Pulse 2.0

Aptinyx Stock Price Increased Over 4% Pre-Market: Why It Happened


Save $400 on Eargo Neo HiFi, next-generation invisible in-ear hearing aids

Pulse 2.0

SomaLogic Adds $81 Million To Current Funding Round, Bringing Total To $214 Million


Save $295 on Eargo's invisible in-ear hearing aids

$71,000,000 Venture capital (Series E)
FinSMEs , Pulse 2.0

Eargo Raises $71M in Series E Financing


Eargo raises $71 million to bring its connected hearing aids to more people


Engrail Therapeutics Raises $32M in Series A Financing

$32,000,000 Venture capital (Series A)
Xconomy , neurons.AI

Engrail Therapeutics Launches With $32M to Develop New Neuro Drugs

$6,000,000 Venture capital (Series A)

Fountain Therapeutics Closes $6M Series A-1 Financing


Aptinyx Moves Ahead With PTSD Therapy Study, Pauses 3 Other Trials


Omniome Raises $60M in Series C Financing


Eargo’s latest hearing aid improves bandwidth and noise cancellation

the home of AI info

Aptinyx to Present Preclinical Data on Three Clinical-Stage NMDA Receptor Modulators at the 49th ...

$52,000,000 Venture capital (Series D)
FinSMEs , PE HUB , TechCrunch

Eargo Raises Over $52M in Series D Funding Round

Silicon Canals

Swiss startup Oculis secures €13.8M funding to treat ophthalmic diseases

$15,711,870 Venture capital (Series B)

Oculis Raises CHF15.5M in Extension of Series B Financing